[Counteracting the sigma. Lipodystrophy decreases prognosis and quality of life].
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000523:psychology*; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy / Q000209:etiology / Q000523:psychology*; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D011287:Prejudice; D011379:Prognosis; D011788:Quality of Life / Q000523:psychology*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D011994:Recombinant Proteins; D019382:Human Growth Hormone